BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 7562019)

  • 21. Biochemically targeted therapy of refractory leukemia and myeloid blast crisis of chronic granulocytic leukemia with Tiazofurin, a selective blocker of inosine 5'-phosphate dehydrogenase activity.
    Tricot G; Weber G
    Anticancer Res; 1996; 16(6A):3341-7. PubMed ID: 9042309
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preclinical antitumor activity of temozolomide in mice: efficacy against human brain tumor xenografts and synergism with 1,3-bis(2-chloroethyl)-1-nitrosourea.
    Plowman J; Waud WR; Koutsoukos AD; Rubinstein LV; Moore TD; Grever MR
    Cancer Res; 1994 Jul; 54(14):3793-9. PubMed ID: 8033099
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cytosine arabinoside (ara-C) and cis-dichlorodiammineplatinum II (cisplatin) alone and in combination: effects on acute myeloblastic leukemia blast cells in culture and in vivo.
    Wang YF; Curtis JE; Lipton J; Minkin S; McCulloch EA
    Leukemia; 1991 Jun; 5(6):522-7. PubMed ID: 1711641
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Low O6-alkylguanine DNA alkyltransferase activity in the peripheral blood lymphocytes of patients with therapy-related acute nonlymphocytic leukemia.
    Sagher D; Karrison T; Schwartz JL; Larson R; Meier P; Strauss B
    Cancer Res; 1988 Jun; 48(11):3084-9. PubMed ID: 2452685
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The level of glycolytic metabolism in acute myeloid leukemia blasts at diagnosis is prognostic for clinical outcome.
    Herst PM; Howman RA; Neeson PJ; Berridge MV; Ritchie DS
    J Leukoc Biol; 2011 Jan; 89(1):51-5. PubMed ID: 20959411
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Urinary excretion of proteolyzed alpha1-antitrypsin: specificity, quantitation, and relation to therapy response in patients with acute myeloid leukemia.
    Dengler R; Plewan A; Münstermann U; Busch R; Eger G; Emmerich B
    Clin Cancer Res; 1995 Feb; 1(2):199-205. PubMed ID: 9815974
    [TBL] [Abstract][Full Text] [Related]  

  • 27. O6-alkylguanine-DNA alkyltransferase depletion and regeneration in human peripheral lymphocytes following dacarbazine and fotemustine.
    Lee SM; Thatcher N; Margison GP
    Cancer Res; 1991 Jan; 51(2):619-23. PubMed ID: 1824685
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Idarubicin in acute leukemia: results of studies at Memorial Sloan-Kettering Cancer Center.
    Berman E; Raymond V; Gee T; Kempin SJ; Gulati S; Andreeff M; Kolitz J; Gabrilove J; Heller G; Young CW
    Semin Oncol; 1989 Feb; 16(1 Suppl 2):30-4. PubMed ID: 2928808
    [No Abstract]   [Full Text] [Related]  

  • 29. Inhibition of telomerase activity with hTERT antisense increases the effect of CDDP-induced apoptosis in myeloid leukemia.
    Yuan Z; Mei HD
    Hematol J; 2002; 3(4):201-5. PubMed ID: 12189566
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of O6-benzylguanine analogues on sensitivity of human tumor cells to the cytotoxic effects of alkylating agents.
    Dolan ME; Mitchell RB; Mummert C; Moschel RC; Pegg AE
    Cancer Res; 1991 Jul; 51(13):3367-72. PubMed ID: 1647266
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Standard induction chemotherapy followed by attenuated consolidation in elderly patients with acute myeloid leukemia.
    Lee JH; Choi SJ; Lee JH; Park JH; Kim H; Joo YD; Lee WS; Zang DY; Kim HJ; Lee KH;
    Ann Hematol; 2006 Jun; 85(6):357-65. PubMed ID: 16575580
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clearance of leukaemic blasts from peripheral blood during standard induction treatment predicts the bone marrow response in acute myeloid leukaemia: a pilot study.
    Gianfaldoni G; Mannelli F; Baccini M; Antonioli E; Leoni F; Bosi A
    Br J Haematol; 2006 Jul; 134(1):54-7. PubMed ID: 16803567
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Depletion of O6-alkylguanine alkyltransferase and chromosome damage induced by cisplatin, ning xin platin and carboplatin].
    Wang LG; Liu XM; Fan PD; Ji XJ
    Yao Xue Xue Bao; 1991; 26(8):561-6. PubMed ID: 1805517
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome.
    Druker BJ; Sawyers CL; Kantarjian H; Resta DJ; Reese SF; Ford JM; Capdeville R; Talpaz M
    N Engl J Med; 2001 Apr; 344(14):1038-42. PubMed ID: 11287973
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Five cases of de novo acute myeloid leukemia with trilineage myelodysplasia (AML/TMDS) achieved CR with the continuous drip infusion of low-dose etoposide and low-dose cytosine arabinoside combined with mitoxantrone (MEtA)].
    Tsukaguchi M; Furukawa Y; Shibano M; Kitani T
    Gan To Kagaku Ryoho; 2004 Jul; 31(7):1119-23. PubMed ID: 15272598
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Flow cytometric detection of proliferative cells in leukemias.
    Wakita A; Nitta M; Mitomo Y; Takahashi M; Tanaka M; Kaneda T
    Jpn J Cancer Res; 1994 Feb; 85(2):204-10. PubMed ID: 8144401
    [TBL] [Abstract][Full Text] [Related]  

  • 37. O6-alkylguanine-DNA alkyltransferase activity in blasts obtained from patients with myelogenous or lymphocytic leukemia.
    D'Atri S; Papa G; Tuorto V; Piccioni D; Franchi A; Del Poeta G; Bonmassar E
    Pharmacol Res; 1992 Sep; 26 Suppl 2():78-9. PubMed ID: 1409331
    [No Abstract]   [Full Text] [Related]  

  • 38. Chemotherapy of acute myeloid leukemia of 35- to 60-year-old patients.
    Fleischer J; Reinhardt U; Wolf H; Helbig W; Anger G; Grau I; Schott G; Konrad H; Klinkenstein C; Steglich J
    Haematol Blood Transfus; 1990; 33():392-4. PubMed ID: 2323648
    [No Abstract]   [Full Text] [Related]  

  • 39. Localized leukemic pulmonary infiltrates. Diagnosis by bronchoscopy and resolution with therapy.
    Kovalski R; Hansen-Flaschen J; Lodato RF; Pietra GG
    Chest; 1990 Mar; 97(3):674-8. PubMed ID: 2407452
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Drug-induced xenogenization of tumors: A possible role in the immune control of malignant cell growth in the brain?
    Franzese O; Battaini F; Graziani G; Tentori L; Barbaccia ML; Aquino A; Roselli M; Fuggetta MP; Bonmassar E; Torino F
    Pharmacol Res; 2018 May; 131():1-6. PubMed ID: 29530602
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.